Pharmaceutical Sample Clauses

Pharmaceutical. (1) The Supplier may in its absolute discretion determine from time to time a “Specified Order Quantity”, being the minimum order value or quantity for each order of Products to be supplied to Customer. Pharmaceutical orders with a value of less than A$500.00 will incur a service charge at Supplier’s discretion (2) Two free into store/agreed deliver point(s) orders per month will be supplied providing each order has an invoice value of not less than A$500.00. Further orders may incur freight charges at Supplier’s discretion. (3) Where Customer requires Supplier to freight the goods to Customer urgently, or in a manner which is not usually used by Supplier, Supplier reserves the right to charge Customer for any additional freight expenses incurred.

Pharmaceutical. (1) The Supplier will only supply restricted medicines where you hold the appropriate licence with the Medicines and Medical Devices Safety Authority to purchase such goods. (2) The Supplier will only supply you with goods or services on credit when the Supplier has obtained a credit check satisfactory to the Supplier’s requirements (3) The Supplier may in its absolute discretion determine from time to time a “Specified Order Quantity”, being the minimum order value or quantity for each order of products to be supplied to Customer. Pharmaceutical orders with a value of less than NZD$1,000.00 will incur a service charge at the Supplier’s discretion (4) If an order has an invoice value of not less than NZD$1,000.00, Supplier will arrange for One Weekly Order to be supplied free to individually agreed delivery points (“Freight-Free Level”). Further orders may incur freight charges at Supplier’s discretion. (5) Where Customer requires Supplier to freight the goods to Customer urgently, or in a manner which is not usually used by Supplier, Supplier reserves the right to charge Customer for any additional freight expenses incurred.

Pharmaceutical. (1) The Customer must notify the Supplier by telephone on +00 0 0000 0000 (immediately confirmed in writing) immediately after it becomes aware of any information (whether credible or otherwise) which may give rise to a recall of the goods. (2) Without limiting clause (1) above, the Customer must notify the Supplier as soon as is practicable after it becomes aware of any adverse publicity or threatened or pending legal proceedings with respect to the goods or of any other information that might adversely impact upon the goodwill associated with the Supplier or the goods. (3) The Customer will communicate any reports of Human Safety Information, quality complaints, or suspected counterfeits relating to the Supplier’s pharmaceutical products to GSK Australia Medical Information on 1800 033 109 or +00 0 0000 0000 within 24 hours of initial awareness.

Pharmaceutical. (1) The Customer must notify the Supplier by telephone on 0000 000 000 (immediately confirmed in writing) immediately after it becomes aware of any information (whether credible or otherwise) which may give rise to a recall of the goods. (2) Without limiting clause (1) above, the Customer must notify the Supplier as soon as is practicable after it becomes aware of any adverse publicity or threatened or pending legal proceedings with respect to the goods or of any other information that might adversely impact upon the goodwill associated with the Supplier or the goods. (3) The Customer will report technical or quality complaints or suspected counterfeits relating to pharmaceutical products to GSK New Zealand on 0800 808 500 or +00 00 000 0000 within 24 hours of initial awareness. Complaints samples if available must be securely retained and provided to the Supplier upon request.

Pharmaceutical. (1) The Customer must notify the Supplier by telephone on +00 0 0000 0000 (immediately confirmed in writing) immediately after it becomes aware of any information (whether credible or otherwise) which may give rise to a recall of the goods. (2) Without limiting clause (1), the Customer must notify the Supplier as soon as is practicable after it becomes aware of any adverse publicity or threatened or pending legal proceedings with respect to the goods or of any other information that might adversely impact upon the goodwill associated with the Supplier or the goods. (3) The Customer will report Human Safety Information for Pharmaceutical Products or suspected counterfeit Pharmaceutical Products to GSK Australia Medical Information on 1800 033 109 or +00 0 0000 0000 within 24 hours of initial awareness. (4) The Customer will report Technical or Quality complaints relating to Pharmaceutical Products to the Supplier on +00 0 0000 0000 within 24 hours of initial awareness. Complaints samples if available must be securely retained and provided to the Supplier upon request.

Pharmaceutical. The Contractor shall provide for pharmaceutical management services to assure the availability of prescribed medications within a reasonable time period of the order of issue being written ex- cept where such medications are not readily available in the local community. In order to facili- xxxx the timely administration of medications, the Agency agrees to allow the use of an inmate’s home medication, as appropriate, upon the verification of the medication by Contractor person- nel. The Contractor shall provide a method for the recording of the administration of medications by Agency and/or Contractor personnel on a pre-approved form that includes documentation of the fact that inmates are receiving and ingesting their prescribed medications. Medication admin- istration and medication documentation training shall be made available for Agency staff, upon request, for times when Contractor personnel are not at the Facility to administer medications. The Contractor will negotiate discounted rates with a pharmacy licensed in the State of Colora- do. The Contractor will be responsible to pay the costs of all pharmaceutical as required by cur- rent applicable law with the exception of “specific medications”, and subject to the Maximum Liability provision listed below in Subsection 1.9. For the purpose of this agreement, “specific medications” shall be defined as any court ordered medications, medication related to the treat- ment of HIV/AIDS related to diseases, hemophilia, hepatitis, cystic fibrosis, multiple sclerosis, cancer, active tuberculosis, medications for juveniles, as well as medications listed as biological and/or anti-rejection drugs.

Pharmaceutical particulars The capsules are not intended to be opened. Atomoxetine is an ocular irritant. In the unlikely event that the capsule contents come into contact with the eyes then the eyes should be flushed immediately with water.

Pharmaceutical. Capsules

Pharmaceutical. The Contractor shall provide a complete pharmaceutical system for inmates housed at the Facility. The Contractor will be responsible to pay the costs ofpharmaceuticals and pharmaceutical supplies as required by current applicable law. The cost for pharmaceuticals, medications and associated supplies required to treat blood or organ disease (i.e., hemophilia, hepatitis) shall be limited to $25,000.00 per year and shall be applied to the Maximum Limit defined in Section 1.9. Costs exceeding the $25,000.00 limit shall be the responsibility of the Agency. Non-reimbursed pharmaceutical costs incurred by the Contractor for providing health services to Federal Inmates (ICE, USM, FBOP, BIA, etc.) shall also be applied to the maximum financial limit established in Section 1.9. The maximum financial limit shall be pro-rated for any partial year of services. The Contractor shall provide for pharmaceutical services to assure the availability of prescribed medications within a reasonable time period ofthe order ofissue being written except where such medications are not readily available in the local community. Pharmaceutical services shall be consistent with State and Federal regulations and must be monitored by a licensed qualified pharmacist. The Agency agrees to allow the use of an Inmate's home medication, as appropriate, upon the verification of the medication by Contractor personnel. The Contractor shall provide for the recording of the administration of medications in a manner that includes documentation of the fact that inmates are receiving and ingesting their prescribed medications. Documentation will also be required when an inmate's ordered medication was not administered, or the wrong medication administered, and the acts and circumstances regarding the administration.

Pharmaceutical. The Contractor shall provide for pharmaceutical management services to assure the availability of prescribed medications within a reasonable time period of the order of issue being written except where such medications are not readily available in the local community. In order to facilitate the timely administration of medications, the Agency agrees to allow the use of a juvenile resident’s home medication, as appropriate, upon the verification of the medication by Contractor personnel. The Contractor shall provide a method for the recording of the administration of medications by properly authorized Agency personnel and/or Contractor personnel on a pre-approved form that includes documentation of the fact that juvenile residents are receiving and ingesting their prescribed medications. Medication administration and medication documentation training shall be made available for Agency staff, upon request, for times when Contractor personnel are not at the Facility to administer medications. It will be the responsibility of the Agency to pass medication, through properly trained and authorized personnel, when Contractor staff is not present in the facility. The Contractor will negotiate discounted rates with a pharmacy licensed in the State of Oklahoma. The Agency will be responsible to pay, or seek payment from appropriate third parties, for the costs of all pharmaceuticals as required by current applicable law.